BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND TSC1, KIAA0243, 7248, ENSG00000165699, TSC, MGC86987, LAM, hamartin
171 results:

  • 1. Epithelioid angiomyolipoma of the liver in a patient with Li-Fraumeni syndrome: a case report.
    Yang Y; Lee J; Woo CG; Lee OJ; Son SM
    Diagn Pathol; 2024 Jan; 19(1):16. PubMed ID: 38243242
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Multi-cohort validation study of a four-gene signature for risk stratification and treatment response prediction in hepatocellular carcinoma.
    Liu C; Xiao Z; Wu S; Yang Z; Ji G; Duan J; Zhou T; Cao J; Liu X; Xu F
    Comput Biol Med; 2023 Dec; 167():107694. PubMed ID: 37956625
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The relationship between the use of nucleos(t)ide analogs and metabolic parameters in patients with chronic hepatitis B.
    Yakut A; Aladag M
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9315-9323. PubMed ID: 37843345
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma.
    Cowzer D; White JB; Chou JF; Chen PJ; Kim TH; Khalil DN; El Dika IH; Columna K; Yaqubie A; Light JS; Shia J; Yarmohammadi H; Erinjeri JP; Wei AC; Jarnagin W; Do RKG; Solit DB; Capanu M; Shah RH; Berger MF; Abou-Alfa GK; Harding JJ
    JCO Precis Oncol; 2023 Sep; 7():e2300272. PubMed ID: 37769223
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. tsc2 inactivation, low mutation burden and high macrophage infiltration characterise hepatic angiomyolipomas.
    Giannikou K; Klonowska K; Tsuji J; Wu S; Zhu Z; Probst CK; Kao KZ; Wu CL; Rodig S; Marino-Enriquez A; Zen Y; Schaefer IM; Kwiatkowski DJ
    Histopathology; 2023 Oct; 83(4):569-581. PubMed ID: 37679051
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice.
    Zhang J; Lin XT; Yu HQ; Fang L; Wu D; Luo YD; Zhang YJ; Xie CM
    Exp Mol Med; 2023 Oct; 55(10):2162-2176. PubMed ID: 37653031
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
    Navale P; Chatterjee D; Itani M; Trikalinos NA
    Virchows Arch; 2023 Aug; 483(2):167-175. PubMed ID: 37354253
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Tuberous sclerosis associated lymphangioleiomyomatosis: A case report.
    Mushir A; Akhtar S; Hussain M
    J Pak Med Assoc; 2023 Apr; 73(4):908-911. PubMed ID: 37052013
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Role of follistatin-like protein 1 in liver diseases.
    Gu C; Xue H; Yang X; Nie Y; Qian X
    Exp Biol Med (Maywood); 2023 Feb; 248(3):193-200. PubMed ID: 36533576
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. GCHA-Net: Global context and hybrid attention network for automatic liver segmentation.
    Liu H; Fu Y; Zhang S; Liu J; Wang Y; Wang G; Fang J
    Comput Biol Med; 2023 Jan; 152():106352. PubMed ID: 36481761
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Interim Analysis of a Prospective Validation of 2 Blood-Based Genomic Assessments (PPQ and NETest) to Determine the Clinical Efficacy of
    Bodei L; Raj N; Do RK; Mauguen A; Krebs S; Reidy-Lagunes D; Schöder H
    J Nucl Med; 2023 Apr; 64(4):567-573. PubMed ID: 36396457
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Uterine Leiomyosarcoma Masquerading as a Malignant Perivascular Epithelioid Cell Tumor: A Diagnostic Challenge.
    Natsume T; Yoshida H; Nishikawa T; Kikkawa N; Naka T; Kobayashi-Kato M; Tanase Y; Uno M; Ishikawa M; Kato T
    Int J Surg Pathol; 2023 Aug; 31(5):778-784. PubMed ID: 36310451
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Parapelvic Cysts: An Imaging Marker of Kidney Disease Potentially Leading to the Diagnosis of Treatable Rare Genetic Disorders? A Narrative Review of the Literature.
    Capuano I; Buonanno P; Riccio E; Crocetto F; Pisani A
    J Nephrol; 2022 Nov; 35(8):2035-2046. PubMed ID: 35749008
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. E2F7 promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantation.
    Ling S; Zhan Q; Jiang G; Shan Q; Yin L; Wang R; Que Q; Wei X; Xu S; Yu J; Zhou W; Zhang L; Bao J; Ye Q; Su R; Wei R; Liu J; Chen K; Wang J; Xie H; Zheng S; He X; Xiang J; Xu X
    Am J Transplant; 2022 Oct; 22(10):2323-2336. PubMed ID: 35729702
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. tsc22D4 promotes TGFβ1-induced activation of hepatic stellate cells.
    Sakurai M; Weber P; Wolff G; Wieder A; Szendroedi J; Herzig S; Ekim Üstünel B
    Biochem Biophys Res Commun; 2022 Aug; 618():46-53. PubMed ID: 35714570
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. DYRK1A reinforces epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma via cooperatively activating STAT3 and SMAD.
    Li YL; Zhang MM; Wu LW; Liu YH; Zhang ZY; Zeng LH; Lin NM; Zhang C
    J Biomed Sci; 2022 Jun; 29(1):34. PubMed ID: 35655269
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Hepatocyte-specific activity of tsc22D4 triggers progressive NAFLD by impairing mitochondrial function.
    Wolff G; Sakurai M; Mhamane A; Troullinaki M; Maida A; Deligiannis IK; Yin K; Weber P; Morgenstern J; Wieder A; Kwon Y; Sekar R; Zeigerer A; Roden M; Blüher M; Volk N; Poth T; Hackert T; Wiedmann L; De Angelis Rigotti F; Rodriguez-Vita J; Fischer A; Mukthavaram R; Limphong P; Tachikawa K; Karmali P; Payne J; Chivukula P; Ekim-Üstünel B; Martinez-Jimenez CP; Szendrödi J; Nawroth P; Herzig S
    Mol Metab; 2022 Jun; 60():101487. PubMed ID: 35378329
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Integrated Analysis Highlights the Immunosuppressive Role of TREM2
    Zhou L; Wang M; Guo H; Hou J; Zhang Y; Li M; Wu X; Chen X; Wang L
    Front Immunol; 2022; 13():848367. PubMed ID: 35359989
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prevalence of thoracoabdominal imaging findings in tuberous sclerosis complex.
    Ritter DM; Fessler BK; Ebrahimi-Fakhari D; Wei J; Franz DN; Krueger DA; Trout AT; Towbin AJ
    Orphanet J Rare Dis; 2022 Mar; 17(1):124. PubMed ID: 35292049
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Economic Evaluation of Oral Nucleos(t)ide Analogues for Patients with Chronic Hepatitis B in Thailand.
    Dilokthornsakul P; Sawangjit R; Tangkijvanich P; Chayanupatkul M; Tanwandee T; Sukeepaisarnjaroen W; Sriuttha P; Permsuwan U
    Appl Health Econ Health Policy; 2022 Jul; 20(4):587-596. PubMed ID: 35141850
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.